Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Vaklavas

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 6, 2014
Management of metastatic breast cancer with second-generation antibody-drug conjugates: focus on glembatumumab vedotin (CDX-011, CR011-vcMMAE)Christos Vaklavas, Andres Forero
Expert Review of Cardiovascular Therapy|December 21, 2010
The changing perspective of cardiology in cancer careChristos Vaklavas, Yiannis S Chatzizisis
Current Treatment Options in Oncology|November 4, 2011
How do I treat "triple-negative" diseaseChristos Vaklavas, Andres Forero-Torres
Therapeutic Advances in Hematology|April 23, 2013
Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphomaChristos Vaklavas, Andres Forero-Torres
Oncology and Therapy|September 11, 2025
Real-World Studies and Randomized Controlled Trials: A Podcast Discussion of the Relative Strengths and Limitations of These Complementary Designs for Cancer ResearchAdam Brufsky, Christos Vaklavas, Joanne C Ryan
Frontiers in Oncology|August 12, 2017
Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker DevelopmentChristos Vaklavas, Scott W Blume, William E Grizzle
APL Bioengineering|June 9, 2021
Erratum: "Toward improved models of human cancer" [APL Bioeng. <b>5</b>, 010901 (2021)]Bryan E Welm, Christos Vaklavas, Alana L Welm
Pharmacology & Therapeutics|February 1, 2011
Common cardiovascular medications in cancer therapeuticsChristos Vaklavas, Yiannis S Chatzizisis, Apostolia Maria Tsimberidou
The American Journal of Cardiology|March 25, 2008
Coenzyme Q10 depletion: etiopathogenic or predisposing factor in statin associated myopathy?Yiannis S Chatzizisis, Christos Vaklavas, George D Giannoglou
APL Bioengineering|January 8, 2021
Toward improved models of human cancerBryan E Welm, Christos Vaklavas, Alana L Welm
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 6, 2014
Management of metastatic breast cancer with second-generation antibody-drug conjugates: focus on glembatumumab vedotin (CDX-011, CR011-vcMMAE)Christos Vaklavas, Andres Forero
Expert Review of Cardiovascular Therapy|December 21, 2010
The changing perspective of cardiology in cancer careChristos Vaklavas, Yiannis S Chatzizisis
Current Treatment Options in Oncology|November 4, 2011
How do I treat "triple-negative" diseaseChristos Vaklavas, Andres Forero-Torres
Therapeutic Advances in Hematology|April 23, 2013
Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphomaChristos Vaklavas, Andres Forero-Torres
Oncology and Therapy|September 11, 2025
Real-World Studies and Randomized Controlled Trials: A Podcast Discussion of the Relative Strengths and Limitations of These Complementary Designs for Cancer ResearchAdam Brufsky, Christos Vaklavas, Joanne C Ryan
Frontiers in Oncology|August 12, 2017
Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker DevelopmentChristos Vaklavas, Scott W Blume, William E Grizzle
APL Bioengineering|June 9, 2021
Erratum: "Toward improved models of human cancer" [APL Bioeng. <b>5</b>, 010901 (2021)]Bryan E Welm, Christos Vaklavas, Alana L Welm
Pharmacology & Therapeutics|February 1, 2011
Common cardiovascular medications in cancer therapeuticsChristos Vaklavas, Yiannis S Chatzizisis, Apostolia Maria Tsimberidou
The American Journal of Cardiology|March 25, 2008
Coenzyme Q10 depletion: etiopathogenic or predisposing factor in statin associated myopathy?Yiannis S Chatzizisis, Christos Vaklavas, George D Giannoglou
APL Bioengineering|January 8, 2021
Toward improved models of human cancerBryan E Welm, Christos Vaklavas, Alana L Welm
Pageof 6